BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38438206)

  • 1. Comparison of bacteremic pneumonia caused by
    Li F; Zhu J; Zheng Y; Fang Y; Hu L; Xiong J
    Saudi Med J; 2024 Mar; 45(3):241-251. PubMed ID: 38438206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Prognosis of Hospital-Acquired
    Li F; Zhu J; Hang Y; Chen Y; Gu S; Peng S; Fang Y; Hu L; Xiong J
    Infect Drug Resist; 2023; 16():4977-4994. PubMed ID: 37551280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters.
    Cheng WL; Hsueh PR; Lee CC; Li CW; Li MJ; Chang CM; Lee NY; Ko WC
    J Microbiol Immunol Infect; 2016 Apr; 49(2):208-15. PubMed ID: 25070279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for 30-Day Mortality in Patients with Bacteremic Pneumonia Caused by
    Zhao C; Zheng Y; Hang Y; Chen Y; Liu Y; Zhu J; Fang Y; Xiong J; Hu L
    Int J Gen Med; 2023; 16():6163-6176. PubMed ID: 38164517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by
    Chen IR; Lin SN; Wu XN; Chou SH; Wang FD; Lin YT
    Front Cell Infect Microbiol; 2022; 12():903682. PubMed ID: 35811668
    [No Abstract]   [Full Text] [Related]  

  • 7. Klebsiella pneumoniae Bacteremia is Associated with Higher Mortality in Acute Calculous Cholangitis as Compared to Escherichia coli Bacteremia.
    Chan KS; Shelat VG
    World J Surg; 2022 Jul; 46(7):1678-1685. PubMed ID: 35419623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
    Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2888-93. PubMed ID: 22430969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review.
    Park S; So H; Kim MN; Lee J
    BMC Infect Dis; 2022 Nov; 22(1):866. PubMed ID: 36404302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Lo CL; Lee CC; Li CW; Li MC; Hsueh PR; Lee NY; Ko WC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):355-361. PubMed ID: 26423244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
    Lee S; Han SW; Kim KW; Song DY; Kwon KT
    Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae.
    Rivera-Espinar F; Machuca I; Tejero R; Rodríguez J; Mula A; Marfil E; Cano Á; Gutiérrez-Gutiérrez B; Rodríguez M; Pozo JC; De la Fuente C; Rodriguez-Baño J; Martínez-Martínez L; León R; Torre-Cisneros J
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
    Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
    Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
    Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
    Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.